Authors
Loading...
Narrative review reveals inflammatory biomarkers reliably predict cachexia in multiple myeloma, highlighting their clinical utility over exploratory genetic markers.
Dubaj et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: